Prophylactic dexamethasone regimen reduces infusion-related
The 8 mg dexamethasone pre-medication regimen reduced infusion-related reaction (IRR) rates with intravenous amivantamab to 22.5%, a three-fold decrease from historical 67.4% rates.
Related Clinical Trials:
© Copyright 2024. All Rights Reserved by MedPath